Clinical Trials Directory

Trials / Completed

CompletedNCT00830843

Inhalatorial Sedation in Patient With Subarachnoid Hemorrhage (SAH) Versus Conventional Intravenous Sedation

Inhalatorial Sedation in Patient With SAH Versus Conventional Intravenous Sedation (GAS-SAH)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Azienda Ospedaliera San Gerardo di Monza · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Recent study has shown that inhalatory sedation is a practicable, effective and not risky method in Intensive Care Unit. Sevoflurane effect on cerebral system have been described in previous studies: it causes an increasing of cerebral blood flow and a decrease of oxygen cerebral consumption. Clinical strategy for Subarachnoid Hemorrhage is orientated to increase cerebral blood flow to limit vasospasm phenomena after SAH. Scope of this study is to evaluate the Cerebral Blood Flow variation associated to Isoflurane sedation versus conventional sedation with propofol .

Conditions

Interventions

TypeNameDescription
DRUGPropofolPropofol(3-4 mg/kg/ora)administrated for 2 hours.
DRUGIsofluraneIsoflurane inhalatorial administration for 2 hours at 0.8-1.0% Minimum Alveolar Concentration

Timeline

Start date
2009-01-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2009-01-28
Last updated
2016-08-22

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00830843. Inclusion in this directory is not an endorsement.